Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter
Sales rise 41.41% to Rs 77.38 crore
Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September 2024 as against Rs 14.43 crore during the previous quarter ended September 2023. Sales rose 41.41% to Rs 77.38 crore in the quarter ended September 2024 as against Rs 54.72 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales77.3854.72 41 OPM %13.6919.66 -PBDT6.0310.67 -43 PBT5.5610.01 -44 NP4.5914.43 -68Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 05 2024 | 4:37 PM IST